New Zealand markets open in 3 hours 48 minutes

ABBV Apr 2024 125.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.02000.0000 (0.00%)
As of 09:32AM EDT. Market open.
Full screen
Previous close0.0200
Open0.0200
Bid0.0000
Ask0.1000
Strike125.00
Expiry date2024-04-19
Day's range0.0200 - 0.0200
Contract rangeN/A
Volume2
Open interest37
  • Reuters

    UPDATE 1-US FDA warns of harmful reactions to fake Botox injections

    The U.S. Food and Drug Administration on Tuesday alerted health care professionals and consumers that unsafe counterfeit versions of AbbVie's Botox were given to consumers for cosmetic purposes in multiple states. The U.S. Centers for Disease Control and Prevention (CDC) and the FDA are investigating reports of harmful reactions among people who received injections of counterfeit Botox. As of April 12, a total of 19 people from nine states had reported harmful reactions after receiving Botox injections from unlicensed or untrained individuals, or in non-healthcare settings, such as homes and spas, according to the CDC.

  • Zacks

    AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

    Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

  • Zacks

    Johnson & Johnson (JNJ) Q1 Earnings Top Estimates

    Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 2.65% and 0.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?